Abstract:Induced pluripotent stem cells (iPSCs) have tremendous potential as a tool for disease modeling, drug testing, and other applications. Since the generation of iPSCs "captures" the genetic history of the individual cell that was reprogrammed, iPSC clones (even those derived from the same individual) would be expected to demonstrate genetic heterogeneity. To assess the degree of genetic heterogeneity, and to determine whether some cells are more genetically "fit" for reprogramming, we performed exome sequencing on 24 mouse iPSC clones derived from skin fibroblasts obtained from two different sites of the same 8-week-old C57BL/6J male mouse. While no differences in the coding regions were detected in the two parental fibroblast pools, each clone had a unique genetic signature with a wide range of heterogeneity observed among the individual clones: a total of 383 iPSC variants were validated for the 24 clones (mean 16.0/clone, range 0-45). Since these variants were all present in the vast majority of the cells in each clone (variant allele frequencies of 40-60% for heterozygous variants), they most likely preexisted in the individual cells that were reprogrammed, rather than being acquired during reprogramming or cell passaging. We then tested whether this genetic heterogeneity had functional consequences for hematopoietic development by generating hematopoietic progenitors in vitro and enumerating colony forming units (CFUs). While there was a range of hematopoietic potentials among the 24 clones, only one clone failed to differentiate into hematopoietic cells; however, it was able to form a teratoma, proving its pluripotent nature. Further, no specific association was found between the mutational spectrum and the hematopoietic potential of each iPSC clone. These data clearly highlight the genetic heterogeneity present within individual fibroblasts that is captured by iPSC generation, and suggest that most of the changes are random, and functionally benign.

Large-Scale Profiling Reveals the Influence of Genetic Variation on Gene Expression in Human Induced Pluripotent Stem Cells

Induced Pluripotent Stem Cells and Embryonic Stem Cells Are Distinguished by Gene Expression Signatures

Deconstructing Transcriptional Heterogeneity in Pluripotent Stem Cells

Genetic heterogeneity of induced pluripotent stem cells: results from 24 clones derived from a single C57BL/6 mouse

Single-cell RNA-sequencing of differentiating iPS cells reveals dynamic genetic effects on gene expression

Molecular and functional variation in iPSC-derived sensory neurons

Identification of the New Gene Zrsr1 to Associate with the Pluripotency State in Induced Pluripotent Stem Cells (ipscs) Using High Throughput Sequencing Technology.

A genome-scale single cell CRISPRi map of trans gene regulation across human pluripotent stem cell lines

MicroRNA Profiling of Human-Induced Pluripotent Stem Cells.

Low Incidence of DNA Sequence Variation in Human Induced Pluripotent Stem Cells Generated by Nonintegrating Plasmid Expression.

The gene expression profiles of induced pluripotent stem cells (iPSCs) generated by a non-integrating method are more similar to embryonic stem cells than those of iPSCs generated by an integrating method.

Single Cell Transcriptional Profiling Reveals Heterogeneity of Human Induced Pluripotent Stem Cells

Population-scale single-cell RNA-seq profiling across dopaminergic neuron differentiation

Genome-wide CNV Analysis in Mouse Induced Pluripotent Stem Cells Reveals Dosage Effect of Pluripotent Factors on Genome Integrity

Need for high-resolution Genetic Analysis in iPSC: Results and Lessons from the ForIPS Consortium

Complex regulatory networks influence pluripotent cell state transitions in human iPSCs

Quantitative Proteomic Analysis of Mouse Embryonic Fibroblasts and Induced Pluripotent Stem Cells Using 16O/18O Labeling.

Comparable frequencies of coding mutations and loss of imprinting in human pluripotent cells derived by nuclear transfer and defined factors.

Identifying Candidate Reprogramming Genes in Mouse Induced Pluripotent Stem Cells

Residual expression of reprogramming factors affects the transcriptional program and epigenetic signatures of induced pluripotent stem cells

Reassessment of marker genes in human induced pluripotent stem cells for enhanced quality control